RecruitingNCT07362693

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Qianfoshan Hospital
Intervention
Biologic Agent(drug)
Enrollment
50 enrolled
Eligibility
18 years · All sexes
Timeline
20252028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07362693 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials